Learn how to use blocking and binding assays and the Opto Viral Neutralization 1.0 workflow to identify cross-reactive antibodies that may have broad neutralization capacity across the coronavirus family.

Please fill out the following form to access this resource:

First Name*
Last Name*
Email Address*
Phone Number*
City*
Country*
State*
Company/Institute*
CAPTCHA

Related Resources

View All Resources

Antibody Discovery

Antibody Discovery Webinar: Digital Week 2018

Watch a 1-hour webinar from the 2018 Antibody Engineering & Therapeutics Digital Week titled, “Emerging Technologies for Finding Rare Antibodies,” featuring scientists from Berkeley Lights and Teva Pharmaceuticals.

Antibody Discovery

Brochure: Antibody Discovery

Find out how Opto™ Plasma B Discovery using the Beacon^® optofluidic system accelerates lead molecule discovery against difficult targets.

Antibody Discovery

Application Note: Rapidly Discover and Select Potent Ligand/ Receptor Blocking Antibody Lead Candidates with Opto™ Plasma B Discovery

Discover how you can maximize hit recovery and rapidly down-select blocking antibodies from plasma B cells in a single day.